InsiderTrades

Marks Gilbert Lynn

SEC CIK 1916940 · EDGAR

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ANTXAN2 Therapeutics, Inc.Dir 81.9K — — 72024-12-192026-07-10

Most active insiders at ANTX, 12 months

#InsiderTitleBoughtSold
1 Readnour Robin ShaneDir —$316.7K
2 Eizen Joshua MSee Remarks —$52.9K
3 FitzPatrick Margaret MDir $11.6K—
4 Chanda SanjayChief Development Off —$9,311
5 Day LucyCFO —$8,862
6 Prior Stephen DavidChief Strategy Off —$7,363
7 Williams Sarah JoannePrincipal Accounting Off —$3,025
8 Trenor Cameron C. IIIChief Medical Off ——
9 Marks Gilbert LynnDir ——
10 Martin Patricia A.Dir ——

Transactions 7

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
2026-07-10 19:41 2026-07-10 ANTX AN2 Therapeutics, Inc. Marks Gilbert Lynn Dir A - Grant $0.00 +2,789 81.9K +4% $0
2026-04-10 20:53 2026-04-10 ANTX AN2 Therapeutics, Inc. Marks Gilbert Lynn Dir A - Grant $0.00 +3,775 79.1K +5% $0
2026-01-14 2026-01-12 ANTX AN2 Therapeutics, Inc. Marks Gilbert Lynn Dir A - Grant $0.00 +11.6K 75.3K +18% $0
2025-10-14 2025-10-10 ANTX AN2 Therapeutics, Inc. Marks Gilbert Lynn Dir A - Grant $0.00 +10.4K 63.7K +19% $0
2025-07-11 2025-07-10 ANTX AN2 Therapeutics, Inc. Marks Gilbert Lynn Dir A - Grant $0.00 +11.9K 53.4K +29% $0
2025-04-11 2025-04-10 ANTX AN2 Therapeutics, Inc. Marks Gilbert Lynn Dir A - Grant $0.00 +9,705 41.5K +31% $0
2024-12-23 2024-12-19 ANTX AN2 Therapeutics, Inc. Marks Gilbert Lynn Dir A - Grant $0.00 +8,972 31.8K +39% $0

Purchase Sale Sale after option exercise All abbreviations